Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (421-430 of 560) with videos related to

Pageof 56
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancersClaire F Verschraegen, Wei Hu, Yu Du, et al.
International Journal of Cancer|July 15, 1999
Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185C M Boyer, L Pusztai, J R Wiener, et al.
American Journal of Obstetrics and Gynecology|March 11, 1992
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alphaS Wu, K Rodabaugh, O Martinez-Maza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomasY Yu, F Xu, H Peng, et al.
The Journal of Biological Chemistry|December 13, 2003
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cellsXianjun Fang, Shuangxing Yu, Robert C Bast, et al.
Cell Cycle (Georgetown, Tex.)|December 18, 2009
Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironmentJingfang Zheng, Imelda Mercado-Uribe, Daniel G Rosen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancerUsha Menon, Steven J Skates, Sara Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial TrustF Balkwill, R C Bast, J Berek, et al.
Cancer Research|August 3, 2005
A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cellsArata Nishimoto, Yinhua Yu, Zhen Lu, et al.
Oncotarget|December 23, 2015
NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanismsHailing Yang, Partha Das, Yinhua Yu, et al.
Pageof 56

Showing results (421-430 of 560) with videos related to

Sort By:
Pageof 56
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancersClaire F Verschraegen, Wei Hu, Yu Du, et al.
International Journal of Cancer|July 15, 1999
Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185C M Boyer, L Pusztai, J R Wiener, et al.
American Journal of Obstetrics and Gynecology|March 11, 1992
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alphaS Wu, K Rodabaugh, O Martinez-Maza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomasY Yu, F Xu, H Peng, et al.
The Journal of Biological Chemistry|December 13, 2003
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cellsXianjun Fang, Shuangxing Yu, Robert C Bast, et al.
Cell Cycle (Georgetown, Tex.)|December 18, 2009
Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironmentJingfang Zheng, Imelda Mercado-Uribe, Daniel G Rosen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancerUsha Menon, Steven J Skates, Sara Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial TrustF Balkwill, R C Bast, J Berek, et al.
Cancer Research|August 3, 2005
A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cellsArata Nishimoto, Yinhua Yu, Zhen Lu, et al.
Oncotarget|December 23, 2015
NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanismsHailing Yang, Partha Das, Yinhua Yu, et al.
Pageof 56